Prudent Man Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Buy
6,980
+2,441
+54% +$661K 0.56% 47
2025
Q4
$1.14M Sell
4,539
-82
-2% -$21.8K 0.41% 50
2025
Q3
$1.33M Sell
4,621
-1,695
-27% -$454K 0.49% 46
2025
Q2
$1.66M Buy
6,316
+489
+8% +$119K 0.53% 41
2025
Q1
$1.36M Buy
5,827
+193
+3% +$46.8K 0.49% 37
2024
Q4
$1.29M Sell
5,634
-657
-10% -$151K 0.47% 42
2024
Q3
$1.41M Buy
+6,291
New +$1.38M 0.47% 40
2024
Q2
Sell
-2,650
Closed -$579K 180
2024
Q1
$579K Buy
2,650
+47
+2% +$10.4K 0.22% 112
2023
Q4
$592K Sell
2,603
-57
-2% -$12K 0.22% 104
2023
Q3
$535K Sell
2,660
-506
-16% -$107K 0.21% 109
2023
Q2
$656K Sell
3,166
-49
-2% -$9.51K 0.25% 89
2023
Q1
$634K Sell
3,215
-5
-0.2% -$1.03K 0.25% 93
2022
Q4
$651K Buy
+3,220
New +$629K 0.26% 93

Other funds holding LH

Prudent Man Advisors's LH Position: Q1 2026 in Review

Prudent Man Advisors increased its Labcorp (LH) stake by 54% in Q1 2026, buying an estimated $661K and bringing the position to 6,980 shares worth $1.86M. The position accounts for 0.56% of the portfolio, ranked #47.

Prudent Man Advisors first reported a position in LH in Q4 2022 and has held it in 13 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Prudent Man Advisors held 6,980 shares of Labcorp worth $1.86M as of Q1 2026.
  • Prudent Man Advisors bought 2,441 Labcorp shares in Q1 2026, an estimated $661K.
  • Labcorp made up 0.56% of Prudent Man Advisors's portfolio in Q1 2026, its #47 holding.
  • Prudent Man Advisors first reported a position in Labcorp in Q4 2022 and has held it in 13 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.